Facebook
Twitter
Telegram
Report an ErrorVallon Pharmaceuticals Financial Statements 2011-2024 | VLON
Annual Financial Statements Vallon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
198 K | 55.5 K | 26.2 M | - | - | - | - | - | - | - | - | - | - |
Shares |
462 K | 129 K | 6.54 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
0.43 | 0.43 | 4.88 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-13 M | -3.22 M | -9.3 M | -4.82 M | -3.46 M | -4.31 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | 100 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 100 | - | - | - | - | - | - | - | - | - |
Operating Income |
-11.4 M | -2.24 M | -9.26 M | -4.79 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
250 K | - | 61 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-11.4 M | -2.24 M | -9.26 M | -4.71 M | -3.14 M | -4.31 M | - | - | - | - | - | - | - |
Operating Expenses |
11.4 M | 2.24 M | 9.26 M | 4.89 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.16 M | 2 M | 4.07 M | 1.18 M | 1.27 M | 801 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Vallon Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.12 M | 2.42 M | 449 K | 1 M | 896 K | 851 K | 227 K | 6.81 M | 6.81 M | 6.81 M | 5.71 M | 4.51 M | 4.51 M | 4.51 M | 4.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-2.14 M | -6.75 M | -2.15 M | - | -351 K | -295 K | -302 K | - | -1.26 M | -2.31 M | -2.64 M | - | -1.04 M | -1.15 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.44 M | -5.93 M | -2.35 M | - | -186 K | -189 K | -2.63 M | - | -1.25 M | -2.31 M | -2.6 M | - | -1.03 M | -1.14 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
250 K | - | 16 K | - | 2 K | - | -1 K | - | -4 K | -2 K | -8 K | - | -12 K | -12 K | -2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -2.35 M | - | -186 K | -189 K | -2.63 M | - | -1.25 M | -2.31 M | -2.6 M | - | -1.03 M | -1.14 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.44 M | 5.93 M | 2.35 M | - | 186 K | 189 K | 2.63 M | - | 1.25 M | 2.31 M | 2.6 M | - | 1.03 M | 1.14 M | 1.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.25 M | 5.05 M | 2.47 M | - | 123 K | 130 K | 1.36 M | - | 1.04 M | 1.11 M | 830 K | - | 300 K | 327 K | 375 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency